Chunghwa Chemical Synthesis & Biotech Co., Ltd. Share Price
Equities
1762
TW0001762003
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.15 TWD | +0.65% | +2.67% | -19.60% |
Sales 2024 * | 1.73B 53.46M 4.46B | Sales 2025 * | - | Capitalization | 3.59B 111M 9.26B |
---|---|---|---|---|---|
Net income 2024 * | 207M 6.4M 534M | Net income 2025 * | - | EV / Sales 2024 * | 2.08 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.09% |
1 day | +0.65% | ||
1 week | +2.67% | ||
Current month | -5.53% | ||
1 month | -5.53% | ||
3 months | -11.42% | ||
6 months | -15.48% | ||
Current year | -19.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chung Hsin Huang
CEO | Chief Executive Officer | - | 29/09/29 |
Chun-Ming Chen
CTO | Chief Tech/Sci/R&D Officer | - | 13/17/13 |
Kuan-Chieh Wang
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yin Nan Sun
BRD | Director/Board Member | - | 12/98/12 |
Cheng Hsien Tsai
BRD | Director/Board Member | - | 20/12/20 |
Chung Hsin Huang
CEO | Chief Executive Officer | - | 29/09/29 |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 46.3 | +0.33% | 109,601 |
30/24/30 | 46.15 | +0.65% | 217,258 |
29/24/29 | 45.85 | +2.12% | 202,289 |
26/24/26 | 44.9 | -.--% | 156,181 |
25/24/25 | 44.9 | -0.55% | 112,879 |
End-of-day quote Taiwan S.E., April 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.60% | 110M | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-17.49% | 31.47B | |
+54.44% | 25.24B | |
-13.13% | 15.82B | |
-9.12% | 11.96B | |
-15.45% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- 1762 Stock